CytomX Therapeutics, Inc. - Common Stock —— 现金流量表 (NASDAQ:CTMX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 5.26 M-119.03 M-110.79 M-56.03 M-86.23 M-75.59 M -80.09 M 投资活动产生的现金 -18.72 M22.49 M98.26 M-150.67 M99.7 M-59.74 M -283.12 M 融资活动产生的现金 16.89 M110.21 M648 K30.23 M7.52 M110.45 M 344.93 M 自由现金流 5.26 M-119.03 M-110.79 M-56.03 M-86.23 M-75.81 M -80.19 M

新闻

Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern

5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com

CytomX Therapeutics: Cashed Up With Catalysts Ahead (NASDAQ:CTMX)

CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

CytomX Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:CTMX) 2026-03-17

CytomX launches $250M public offering to fund drug development

Micron and Intel among market cap stock movers on Monday

CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade) (CTMX)